Subscribe
Close
  • Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues

Renew
Inward Investment Guides

Pernix Therapeutics Chooses Morristown, New Jersey, For New Corporate Headquarters

Area Development Online News Desk (04/21/2014)
Pernix Therapeutics Holdings, Inc., a specialty pharmaceutical company primarily focused on the sales, marketing, manufacturing and development of branded pharmaceutical products, signed a lease for new corporate headquarters at 10 North Park Place in Morristown, New Jersey.

“Establishing Pernix’s headquarters in Morristown, New Jersey continues our efforts to build Pernix into a focused specialty pharmaceutical company with an experienced management team that is well-positioned for additional product acquisitions,” Doug Drysdale, President/CEO of Pernix said.

According to the firm, its new corporate headquarters will be occupied in mid-May “and is a key step towards the achievement of several corporate initiatives, including improving the efficiency of the Company’s operational infrastructure by consolidating office locations and hiring and retaining experienced employees.”

“ The Company has shifted its emphasis from horizontal integration to focusing on its core sales and marketing strengths to build a leading specialty pharmaceutical business,” company officials said.

The Company markets a portfolio of branded products, including: CEDAX, an antibiotic for middle ear infections and a number of treatments for cough and cold conditions including ZUTRIPRO, REZIRA and VITUZ. The Company also markets SILENOR, a non-narcotic product for the treatment of insomnia and KHEDEZLA, a treatment for major depressive disorder.

Article Discussion

Share